BSX Q1 2017 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q1 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.2B+10.0% YoY

Gross Profit

$1.4B62.8% margin

Operating Income

$308M14.3% margin

Net Income

$290M13.4% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

-1.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$147M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$17.9B

Total Liabilities

$10.9B

Stockholders' Equity

$7.1B

Cash & Equivalents

$156M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.2B	$2.0B	+10.0%
Gross Profit	$1.4B	$1.4B	-1.1%
Operating Income	$308M	$293M	+5.1%
Net Income	$290M	$202M	+43.6%

Revenue Segments

Cardiovascular

$871M52%

MedSurg

$794M48%